Analyst Ratings for BioNTech (BNTX)

BNTX Rating Summary

BNTX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on BNTX
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $148.67 (-37.1%) * Over Last 12-Mos
Rating Score: 3.3 / 10   Percentile Rank: 29%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/16/2021 Redburn Simon Baker Downgrade Sell
(Neutral)
N/A
(N/A)
220.58
(236.49)
7.21% Details
5/18/2021 Goldman Sachs Chris Shibutani New Coverage Neutral
(N/A)
173.00
(N/A)
198.30
(236.49)
19.26% Details
Like BNTX Ratings? Also take a look at PFE, MRNA, AZN, JNJ

BNTX Ratings News